A new study demonstrates the capability of a streamlined workflow to detect low-level presence of Listeria monocytogenes in ...

The Offering was conducted on a firm commitment basis. AC Sunshine Securities LLC acted as the underwriter for the Offering (the “Underwriter”). Ortoli Rosenstadt LLP acted as U.S. counsel to the ...

The new partnership combines Mainz Biomed’s expertise in DNA-based diagnostics with labor team w’s strong track record in delivering high-quality laboratory services. Together, the companies will ...

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a biotechnology company focused on developing small molecule drugs for viral infections and liver diseases, is navigating a critical phase in its evolution.

The new technology – Cleavage Under Targeted Accessible Chromatin (CUTAC) – focuses on small, fragmented DNA non-coding ...